Feasibility of Evaluating XSTAT Use in the Prehospital Setting
Stopped early · Not applicable
Conditions studied: Shock, Hemorrhagic, Injury Penetrating, Hemorrhage
In brief
This study evaluates the prehospital use of the XSTAT device to control bleeding in junctional wounds. Participants will be randomized to the use of XSTAT versus standard care.
Key facts
- Study ID
- NCT04663087
- Run by
- University of Alabama at Birmingham
- People needed
- 1
- Starts
- 2022-10-29
- Expected to finish
- 2023-08-11
- Last updated by the study team
- 2024-12-30
Who can join
Age: 15 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥15 years or estimated body weight ≥50 kg.
- Penetrating junctional injury (femoral or axillary), with i. visible bleeding ii. too proximal to be controlled with a tourniquet
- Patient will be taken to participating level I trauma center, directly from the scene
You may not qualify if…
- Prisoners, children <15 years old, known pregnant patients.
- Patients receiving chest compressions (prior to XSTAT® use).
- Patients with an opt-out bracelet.
Where it is running
- UAB Hospital — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.